Literature DB >> 7725628

Analysis of leucocytes and lymphocyte subsets for different clinical stages of naturally acquired feline immunodeficiency virus infection.

C Walker1, P J Canfield, D N Love.   

Abstract

We report alterations in leucocytes numbers and lymphocyte subset percentages, determined by flow cytometry, for three observed and previously defined clinical stages (asymptomatic carrier (AC), AIDS-related complex (ARC) and AIDS) of naturally occurring FIV infection. Unstaged FIV-positive cats had significantly lower numbers of total leucocytes (WCC) and neutrophils, lower percentages of PanT+ and CD4+, lower CD4:CD8 ratio and a higher percentage of B cells compared with unstaged FIV-negative cats. When FIV-positive cats were separated into clinical stages and compared with matched FIV-negative cats, AC FIV-positive cats had a significantly lower WCC, lower absolute numbers of neutrophils and lymphocytes, lower percentages of CD4+ and CD8+ cells, lower CD4:CD8 ratios and a higher percentage of B cells than healthy FIV-negative cats. ARC FIV-positive cats had lower percentages of PanT+ and CD4+ cells, lower CD4:CD8 ratios and higher percentages of B cells than matched FIV-negative cats. FIV-positive cats with AIDS had significantly lower percentages of CD4+ cells than matched FIV-negative cats. Comparisons among the three observed clinical stages of FIV-positive cats showed that AC FIV-positive cats had significantly lower WCC, significantly lower absolute numbers of neutrophils and a significantly lower percentage of CD8+ cells than ARC FIV-positive cats. AIDS FIV-positive cats had a significantly lower percentage of B cells than AC or ARC FIV-positive cats. FIV-positive cats had a similar leucocyte response to illness as FIV-negative cats but had consistently lower percentages of CD4+ lymphocytes. Thus, in the staging of FIV, a rise in the percentage of CD8+ lymphocytes could be used to distinguish between AC and ARC and a fall in the percentage of B lymphocytes could distinguish AIDS from AC and ARC.

Entities:  

Mesh:

Year:  1994        PMID: 7725628     DOI: 10.1016/0165-2427(94)90165-1

Source DB:  PubMed          Journal:  Vet Immunol Immunopathol        ISSN: 0165-2427            Impact factor:   2.046


  5 in total

1.  Naturally acquired feline immunodeficiency virus (FIV) infection in cats from western Canada: Prevalence, disease associations, and survival analysis.

Authors:  Madhu Ravi; Gary A Wobeser; Susan M Taylor; Marion L Jackson
Journal:  Can Vet J       Date:  2010-03       Impact factor: 1.008

2.  Parameters of disease progression in long-term experimental feline retrovirus (feline immunodeficiency virus and feline leukemia virus) infections: hematology, clinical chemistry, and lymphocyte subsets.

Authors:  R Hofmann-Lehmann; E Holznagel; P Ossent; H Lutz
Journal:  Clin Diagn Lab Immunol       Date:  1997-01

3.  Assessment of FIV-C infection of cats as a function of treatment with the protease inhibitor, TL-3.

Authors:  Sohela de Rozières; Christina H Swan; Dennis A Sheeter; Karen J Clingerman; Ying-Chuan Lin; Salvador Huitron-Resendiz; Steven Henriksen; Bruce E Torbett; John H Elder
Journal:  Retrovirology       Date:  2004-11-19       Impact factor: 4.602

4.  Prior Puma Lentivirus Infection Modifies Early Immune Responses and Attenuates Feline Immunodeficiency Virus Infection in Cats.

Authors:  Wendy S Sprague; Ryan M Troyer; Xin Zheng; Britta A Wood; Martha Macmillian; Scott Carver; Susan VandeWoude
Journal:  Viruses       Date:  2018-04-20       Impact factor: 5.048

5.  Viral Reservoirs in Lymph Nodes of FIV-Infected Progressor and Long-Term Non-Progressor Cats during the Asymptomatic Phase.

Authors:  C D Eckstrand; C Hillman; A L Smith; E E Sparger; B G Murphy
Journal:  PLoS One       Date:  2016-01-07       Impact factor: 3.240

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.